Lbp Am Sa Takes $6.83 Million Position in Kenvue Inc. $KVUE

Key Points

• Lbp Am Sa has acquired a new stake in Kenvue Inc., purchasing 326,107 shares valued at approximately $6.83 million during the 2nd quarter.
• Kenvue's quarterly earnings report showed $0.29 earnings per share, exceeding analysts' expectations, despite a 4.0% year-over-year revenue decline.
• The company recently increased its quarterly dividend to $0.2075 per share, reflecting a yield of 5.2% and a payout ratio of 112.16%.

Lbp Am Sa acquired a new stake in Kenvue Inc. (NYSE:KVUE - Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 326,107 shares of the company's stock, valued at approximately $6,825,000.

Several other large investors have also made changes to their positions in the business. Vanguard Group Inc. boosted its holdings in shares of Kenvue by 4.9% in the 1st quarter. Vanguard Group Inc. now owns 229,144,387 shares of the company's stock valued at $5,494,882,000 after acquiring an additional 10,600,682 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its holdings in shares of Kenvue by 2.5% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 25,606,238 shares of the company's stock valued at $613,882,000 after acquiring an additional 633,461 shares during the last quarter. Boston Partners boosted its holdings in shares of Kenvue by 7.4% in the 1st quarter. Boston Partners now owns 25,346,453 shares of the company's stock valued at $606,920,000 after acquiring an additional 1,750,490 shares during the last quarter. JPMorgan Chase & Co. boosted its holdings in shares of Kenvue by 11.6% in the 1st quarter. JPMorgan Chase & Co. now owns 24,912,226 shares of the company's stock valued at $597,395,000 after acquiring an additional 2,597,920 shares during the last quarter. Finally, American Century Companies Inc. boosted its holdings in shares of Kenvue by 15.7% in the 1st quarter. American Century Companies Inc. now owns 21,828,854 shares of the company's stock valued at $523,456,000 after acquiring an additional 2,961,716 shares during the last quarter. 97.64% of the stock is owned by hedge funds and other institutional investors.

Kenvue Stock Performance

NYSE:KVUE opened at $15.88 on Thursday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.68 and a current ratio of 0.98. The company has a fifty day moving average of $19.99 and a two-hundred day moving average of $21.68. The stock has a market capitalization of $30.47 billion, a PE ratio of 21.45, a P/E/G ratio of 2.33 and a beta of 0.73. Kenvue Inc. has a fifty-two week low of $15.82 and a fifty-two week high of $25.17.

Kenvue (NYSE:KVUE - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The company reported $0.29 earnings per share for the quarter, topping analysts' consensus estimates of $0.28 by $0.01. The company had revenue of $3.84 billion during the quarter, compared to analysts' expectations of $3.94 billion. Kenvue had a net margin of 9.37% and a return on equity of 20.06%. The firm's revenue for the quarter was down 4.0% on a year-over-year basis. During the same period in the prior year, the business posted $0.32 earnings per share. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. As a group, research analysts forecast that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, August 27th. Shareholders of record on Wednesday, August 13th were given a dividend of $0.2075 per share. This is a boost from Kenvue's previous quarterly dividend of $0.21. This represents a $0.83 dividend on an annualized basis and a yield of 5.2%. The ex-dividend date was Wednesday, August 13th. Kenvue's dividend payout ratio (DPR) is currently 112.16%.

Analyst Upgrades and Downgrades

KVUE has been the topic of several recent research reports. Redburn Partners set a $22.00 price objective on shares of Kenvue in a report on Friday, September 26th. Canaccord Genuity Group decreased their target price on shares of Kenvue from $29.00 to $26.00 and set a "buy" rating for the company in a research note on Friday, August 8th. Citigroup reiterated a "neutral" rating on shares of Kenvue in a research note on Tuesday, September 23rd. Barclays decreased their target price on shares of Kenvue from $20.00 to $17.00 and set an "equal weight" rating for the company in a research note on Wednesday. Finally, Evercore ISI decreased their target price on shares of Kenvue from $23.00 to $18.00 and set an "in-line" rating for the company in a research note on Tuesday, September 23rd. One investment analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of $22.73.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.

Want to see what other hedge funds are holding KVUE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kenvue Inc. (NYSE:KVUE - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.